ArticleAdvances in therapy2019
A Propensity Score Matched Comparison of Brand and Biosimilar Basal Insulin in Non-Critical Hospitalized Patients with Type 2 Diabetes Mellitus.
Xia Hu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.